secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001023024-25-000074
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharma announces NEW DAY clinical trial results; no specifics in filing
---------------------------------------------------------------------------

- Filed Item 8.01 with press release and conference call on NEW DAY Study results.
- Presentation attached as Exhibit 99.1; data not reproduced in the 8-K text.
- No revenue, EPS, or numeric endpoints provided in the filing body.
- Investors should review the full presentation for study outcomes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000074/0001023024-25-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000074/ani-20250723.htm
  HTML page:      https://secwatch.observer/filing/0001023024-25-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer